Ann Arbor, MI: A history of cannabis use is not negatively associated with survival rates among patients receiving liver transplants, according to data published in the journal Clinical Transplantation.
A team of researchers affiliated with the University of Michigan at Ann Arbor reviewed data on post-liver transplantation outcomes in a cohort of 2,690 subjects. They concluded, “Post-LT [liver transplantation] survival was not impacted by self-reported marijuana use history.”
Their finding is consistent with several other studies concluding that marijuana use is not contraindicated in patients receiving organ transplants. Nonetheless, in several states – including some states that permit medical cannabis access – those with a history of marijuana use are ineligible to receive organ transplants.
Full text of the study, “Marijuana use among adult liver transplant candidates and recipients,” appears in Clinical Transplantation.